Elevated LRPPRC expression has also been documented in several malignancies, including gastric, prostate and lung cancers [35, 36], where it correlates with adverse clinical outcomes and is thought to contribute to cancer predisposition and supports its role as a critical factor in tumor progression in gastric cancer [37]. This evidence concerns the gene LRPPRC and lung cancer.